RMTI vs. ECOR, IRIX, FONR, ARAY, RSLS, EDAP, ABT, ISRG, SYK, and BSX
Should you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include electroCore (ECOR), IRIDEX (IRIX), FONAR (FONR), Accuray (ARAY), ReShape Lifesciences (RSLS), Edap Tms (EDAP), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), and Boston Scientific (BSX).
Rockwell Medical (NASDAQ:RMTI) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, media sentiment, profitability, earnings, valuation, dividends, community ranking and analyst recommendations.
Rockwell Medical received 138 more outperform votes than electroCore when rated by MarketBeat users. However, 62.12% of users gave electroCore an outperform vote while only 57.31% of users gave Rockwell Medical an outperform vote.
Rockwell Medical currently has a consensus price target of $7.00, suggesting a potential upside of 298.86%. Given Rockwell Medical's higher possible upside, equities research analysts clearly believe Rockwell Medical is more favorable than electroCore.
23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 1.9% of Rockwell Medical shares are owned by company insiders. Comparatively, 13.1% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Rockwell Medical has higher revenue and earnings than electroCore. Rockwell Medical is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.
Rockwell Medical has a net margin of -9.72% compared to electroCore's net margin of -88.12%. Rockwell Medical's return on equity of -28.29% beat electroCore's return on equity.
In the previous week, Rockwell Medical had 2 more articles in the media than electroCore. MarketBeat recorded 4 mentions for Rockwell Medical and 2 mentions for electroCore. Rockwell Medical's average media sentiment score of 0.73 beat electroCore's score of 0.63 indicating that Rockwell Medical is being referred to more favorably in the media.
Rockwell Medical has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, electroCore has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.
Summary
Rockwell Medical beats electroCore on 12 of the 17 factors compared between the two stocks.
Get Rockwell Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Rockwell Medical Competitors List
Related Companies and Tools
